Dr.Datsons Labs (Delisted) share news and announcements

BSE: 533412

Formerly Aanjaneya Lifecare

Last traded ₹6.40 on 21 May 2015

Delisted on 14 Feb 2020.

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Dr.Datsons Labs quarterly results

Feb14Sat

The board met on 14 Feb 2015 to consider results and others

Notice filed 2 Feb 2015

Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held February 14, 2015, (1) To take on record the Unaudited (Provisional) Financial Results for the Third quarter ended December 31, 2014. (2) Any other matter with the permission of the Chair. The Company has now informed the Exchange that the meeting of the Board of Directors has considered the following: 1. The Appointment of Managing Director of the company. (Purpose Revised) (opens in a new tab)

Dr.Datsons Labs annual reports, presentations and earnings calls

The company's own documents, latest first.Dr.Datsons Labs financials, year by year

Annual reports4

Annual report, year to Mar 2014 (opens in a new tab)11 Sep 2014
Annual report, year to Mar 2013 (opens in a new tab)19 Sep 2013
Annual report, year to Mar 2012 (opens in a new tab)22 Aug 2012
Annual report, year to Mar 2011 (opens in a new tab)6 Sep 2011

Dr.Datsons Labs share news and announcements

899 announcements, routine notices left out, newest first. Page 1 of 18.

Jun 2018
- 18 Jun · Delisting
  Members of the Exchange are hereby notified that in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract (Regulations) Rules, 1957 and Bye Laws & Regulations of National Stock Exchange of India Limited, it has been decided to delist (withdraw the admission to dealings in) equity shares of the Dr. Datson's Labs Limited w.e.f. July 02, 2018. (opens in a new tab)
Feb 2018
- 2 Feb · Public Notice - Compulsory Delisting
  Members of the Exchange are hereby informed that the Exchange on February 02, 2018 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements). (opens in a new tab)
Jun 2015
- 12 Jun · Management
  Dr.Datsons Labs Ltd has informed BSE that the following changes in Directorship of the Company have taken place: 1. The Change in designation of Mr. Rajendra Kamat, as a Non Executive ....
May 2015
- 29 May · Updates
  Dr.Datsons Labs Ltd has informed BSE that the Hon’ble Bombay High Court, while allowing certain application filed by the creditors of the Company in winding up petitions, vide its order ....
- 18 May · Suspension of Trading
  Members of the Exchange are hereby informed that trading in the equity shares of Dr. Datson's Labs Limited will be suspended w.e.f. May 22, 2015 (i.e. closing hours of trading on May 21, 2015) pursuant to order dated 18/02/2015 passed by the Hon ble High Court, Bombay, in Company Petition No. 328 of 2014, the Official Liquidator attached to the said Court has been appointed as the Provisional Liquidator of M/s Dr. Datson's Labs Limited.
- 15 May · Updates
  Dr. Datson's Labs Limited has informed the Exchange that the Company to submit order copy of Bombay High Court dated February 18, 2015 (uploaded on website on March 27, 2015) and Minutes Copy of Official Liquidator dated April 30, 2015. (opens in a new tab)
- 12 May · Management
  Dr. Datson's Labs Limited has informed the Exchange that Mr. Yogesh Patel, has resigned from the post of Company Secretary & Compliance Officer of the Company with effect from May 12, 2015. (opens in a new tab)
- 12 May · Management
  Dr.Datsons Labs Ltd has informed BSE that Mr. Yogesh Patel, has resigned from the post of Company Secretary & Compliance Officer of the Company with effect from May 12, 2015.
- 7 May · Updates
  Dr. Datson's Labs Limited has informed the Exchange that the creditors of the Company in winding up petitions, vide its order dated February 18, 2015 (uploaded on website on March 27, 2015), appointed the official liquidator attached to the Bombay High Court as the provisional liquidator of Dr. Datsons Labs Limited (the Company ) and directed the provisional liquidator to forthwith take charge/possession of the Company s assets, properties, stock in trade, books of account, bank account and all other assets of the Company. (opens in a new tab)
- 7 May · Management
  Dr.Datsons Labs Ltd has informed BSE that the Hon’ble Bombay High Court, while allowing certain application filed by the creditors of the Company in winding up petitions, vide its order ....
Apr 2015
- 30 Apr · Shareholding Pattern For March 31, 2015
  Dr.Datsons Labs Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015. (opens in a new tab)
- 13 Apr · Disclosure
  Vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 13 Apr · Disclosure
  Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 10 Apr · Legal
  Exchange had sought clarification from Dr. Datson's Labs Limited with respect to "Spurt in Price and Volume". The Company has submitted its clarification for the same. (opens in a new tab)
- 10 Apr · Legal
  With reference to the Increase in Price, Dr.Datsons Labs Ltd has Clarified to BSE as under : "The Company is in the process of exploring various strategic moves by formulating policies ....
- 10 Apr · Legal
  Exchange has sought clarification from Dr.Datsons Labs Ltd with reference to increase in price on April 10, 2015. The reply is awaited.
- 6 Apr · Management
  Dr. Datson's Labs Limited has informed the Exchange that Ms. Anjali Jadhav, has been appointed as a Non Executive Additional Director of the Company, with effect from April 2, 2015. (opens in a new tab)
- 3 Apr · Management
  Dr.Datsons Labs Ltd has informed BSE that Ms. Anjali Jadhav, has been appointed as a Non Executive Additional Director of the Company, with effect from April 02, 2015.
Mar 2015
- 18 Mar · Updates on Contract Manufacturing
  Dr.Datsons Labs Ltd has informed BSE that Westminster Pharmaceuticals INC Based out of USA has sent the Company a communication showing interest in Dr. Datsons Labs Ltd contract manufacturing ....
- 18 Mar · Updates
  Dr. Datson's Labs Limited has informed the Exchange that Westminster Pharmaceuticals INC Based out of USA has sent us a communication showing interest in Company's contract manufacturing Generic Medicines in Private Label for Westminster Pharmaceuticals INC. (opens in a new tab)
- 12 Mar · Ochoa Labs to Expand base in Europe through an Exclusive Contract Manufacturing Partnership for Cancer Drugs worth 120 Crore with Dr. Datsons Labs Ltd
  Dr.Datsons Labs Ltd has informed BSE regarding a Press Release dated March 12, 2015, titled "Ochoa Labs to Expand base in Europe through an Exclusive Contract Manufacturing Partnership .... (opens in a new tab)
- 12 Mar · Business
  Dr. Datson's Labs Limited has informed the Exchange regarding a press release dated March 12, 2015 on Ochoa Labs to Expand base in Europe through an Exclusive Contract Manufacturing Partnership for Cancer Drugs worth 120 Crore with Dr.Datsons Labs Ltd. (opens in a new tab)
- 9 Mar · Business
  Dr. Datson's Labs Limited has informed the Exchange regarding press release on Dr. Rajendra Kamat ( VC & MD ) of the Company nominated for Receiving The International Aristotle Award in Turket on March 21 and 22, 2015 at Turkey. (opens in a new tab)
- 9 Mar · Dr. Datsons Labs to partner with Clinton Foundation to supply Anti-Malarial Drugs to Eliminate Malaria on UNITAID-CHAI Malaria Treatment Project 2015
  Dr.Datsons Labs Ltd has informed BSE regarding a Press Release dated March 09, 2015, titled "Dr. Datsons Labs to partner with Clinton Foundation to supply Anti-Malarial Drugs to Eliminate .... (opens in a new tab)
- 9 Mar · Business
  Dr. Datson's Labs Limited has informed the Exchange regarding a press release dated March 9, 2015 titled "Dr. Datsons Labs to partner with Clinton Foundation to supply Anti-Malarial Drugs to Eliminate Malaria on UNITAID-CHAI Malaria Treatment Project 2015". (opens in a new tab)
- 9 Mar · Business
  Dr.Datsons Labs Ltd has submitted to BSE a copy of Press Release on Dr. Rajendra Kamat (VC & MD ) of Dr. Datsons Labs Ltd nominated for Receiving The International Aristotle Award in Turket .... (opens in a new tab)
- 2 Mar · Disclosure
  Dr. Datson's Labs Limited vide letter dated March 2, 2015 has submitted the disclosure, under Regulation 13 (3) and (6) of SEBI (Prohibition of Insider Trading) Regulations, 1992, to the Exchange . (opens in a new tab)
- 2 Mar · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 2 Mar · Business
  Dr.Datsons Labs Ltd has informed BSE regarding a Press Release titled "India's Dr. Datsons Labs Ink Marketing And Supply Agreement with Yemen's AL-MUGDH PHARMA to sell its drugs in YEMEN" (opens in a new tab)
- 2 Mar · Business
  Dr. Datson's Labs Limited has informed the Exchange vide letter dated March 2, 2015 regarding a press release titled "India's Dr. Datsons Labs Ink Marketing And Supply Agreement with Yemen's ALMUGDH PHARMA to sell its drugs in YEMEN". (opens in a new tab)
Feb 2015
- 28 Feb · Disclosure
  Sparrow Asia Diversified Opportunities Fund has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 28 Feb · Disclosure
  Vide letter dated February 27, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 26 Feb · Change in Designation
  Dr.Datsons Labs Ltd has informed BSE that the following changed in designation have taken place for the respective person: 1. Mr. Rajendra Kamath, as a Vice Chairman and Managing ....
- 23 Feb · Updates
  Dr. Datson's Labs Limited has informed the Exchange that the following changes in designation have taken place for the respective person:- 1. Mr. Rajendra Kamath, as a Vice Chairman and Managing Director of the company with effect from February 15, 2015. 2. Mr. Mahesh Vaidya, as Non Executive Chairman of the company with effect from February 15, 2015. (opens in a new tab)
- 14 Feb · Board meeting
  Dr.Datsons Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2015, inter alia, has decided the following: 1. To appoint Mr. ....
- 14 Feb · Results
  Dr. Datson\'s Labs Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 31-Dec-2014. (opens in a new tab)
- 14 Feb · Board meeting
  Dr. Datson's Labs Limited has informed the Exchange that in the Meeting of the Board of Directors of the Company held on February 14, 2015 it was decided: (1) To appoint Mr. Mahesh Vaidya, as the Vice Chairman and Managing Director of the company w.e.f. February 14, 2015. (2) To accept the resignation of Dr. Kannan Vishwanath, as the Vice Chairman and Managing Director of the company w.e.f. February 14, 2015 (opens in a new tab)
- 14 Feb · Results
  Dr.Datsons Labs Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014. (opens in a new tab)
- 9 Feb · Board Meeting on Feb 14, 2015
  Dr.Datsons Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 14, 2015, inter alia: 1. To take on record the Unaudited (Provisional) ....
- 9 Feb · Management
  Dr.Datsons Labs Ltd has informed BSE that Mr. Sameer Talim, Chief Executive officer of the Company, with effect from February 09, 2015.
- 9 Feb · Management
  Dr. Datson's Labs Limited has informed the Exchange regarding appointment of Mr. Sameer Talim, Chief Executive officer of the Company, with effect from February 9, 2015. (opens in a new tab)
- 3 Feb · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 3 Feb · Disclosure
  Vide letter dated February 2, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 2 Feb · Disclosure
  Leman Diversified Fund has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 2 Feb · Board meeting
  Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held February 14, 2015, (1) To take on record the Unaudited (Provisional) Financial Results for the Third quarter ended December 31, 2014. (2) Any other matter with the permission of the Chair. The Company has now informed the Exchange that the meeting of the Board of Directors has considered the following: 1. The Appointment of Managing Director of the company. (Purpose Revised) (opens in a new tab)
Jan 2015
- 30 Jan · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 22 Jan · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 21 Jan · Legal
  Exchange had sought clarification from Dr.Datsons Labs Ltd with respect to news article appearing on PRlog website on January 20, 2015 titled "Belgium Nutraceuticals giant Eubage Laboratory ....
- 20 Jan · Legal
  Exchange has sought clarification from Dr.Datsons Labs Ltd with respect to news article appearing in PRlog website on January 20, 2015 titled "Belgium Nutraceuticals giant Eubage Laboratory ....
- 19 Jan · Shareholding Pattern For December 31, 2014
  Dr.Datsons Labs Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014. (opens in a new tab)

How the price met the news

The first session after each announcement, beside the market.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

13 May 2015Board or managers changeddown 5.00%−6.4 pts vs Nifty 500market median 0.0% · five sessions −21.7% (−25.0 pts vs Nifty 500) · volume 0.1× usual
31 Oct 2014Board or managers changedup 2.26%+0.5 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−2.4 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
7 Apr 2014Board or managers changeddown 0.41%−0.4 pts vs Nifty 500market median 0.0% · five sessions −21.1% (−22.0 pts vs Nifty 500) · volume 0.8× usual
26 Feb 2014Board or managers changeddown 1.90%−2.4 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−2.3 pts vs Nifty 500) · volume 0.2× usual
2 Sep 2013Dividenddown 3.51%−4.9 pts vs Nifty 500market median 0.0% · five sessions +43.4% (+39.9 pts vs Nifty 500) · volume 1.9× usual
31 May 2013Dividenddown 2.87%−0.9 pts vs Nifty 500market median 0.0% · five sessions −12.8% (−10.3 pts vs Nifty 500) · volume 0.8× usual
30 May 2013Dividenddown 6.42%−6.6 pts vs Nifty 500market median 0.0% · five sessions −14.6% (−12.3 pts vs Nifty 500) · volume 0.8× usual
29 May 2013Dividenddown 1.03%−0.8 pts vs Nifty 500market median 0.0% · five sessions −12.3% (−9.7 pts vs Nifty 500) · volume 0.2× usual
16 May 2013Board or managers changeddown 1.64%−2.0 pts vs Nifty 500market median 0.0% · five sessions −8.7% (−7.8 pts vs Nifty 500) · volume 0.7× usual
18 Apr 2013Board or managers changedup 4.94%+3.5 pts vs Nifty 500market median 0.0% · five sessions +4.4% (+1.5 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)

2 earlier announcements

14 Aug 2012Dividendup 0.72%+0.2 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−1.2 pts vs Nifty 500) · volume 0.3× usual
31 May 2012Dividendup 0.17%+0.4 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−0.6 pts vs Nifty 500) · volume 0.1× usual

Sharp moves

The latest 30. 9 of the 30 shown had no filing that day or the next.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

9 Apr 20153 filingsup 19.88%+19.3 pts vs Nifty 5003.6× its usual move · volume 2.0× usual
8 Apr 2015No filing that day or the nextup 19.42%+18.7 pts vs Nifty 5004.0× its usual move · volume 2.3× usual
30 Mar 2015No filing that day or the nextup 10.71%+8.9 pts vs Nifty 5002.5× its usual move · volume 0.8× usual
2 Mar 20154 filingsup 13.53%2.8× its usual move · volume 3.8× usual
21 Jan 20153 filingsup 13.87%+13.6 pts vs Nifty 5002.8× its usual move · volume 1.8× usual
19 Dec 20142 filingsdown 12.24%−12.9 pts vs Nifty 5002.3× its usual move · volume 2.3× usual
18 Dec 2014No filing that day or the nextup 18.50%+16.5 pts vs Nifty 5003.9× its usual move · volume 1.9× usual
26 Nov 201410 filingsup 19.82%+19.6 pts vs Nifty 5004.1× its usual move · volume 4.4× usual
1 Sep 2014No filing that day or the nextup 10.00%+8.8 pts vs Nifty 5002.9× its usual move · volume 0.6× usual
8 May 20148 filingsdown 10.00%−10.1 pts vs Nifty 5001.8× its usual move · volume 2.0× usual

20 earlier moves

23 Apr 2014No filing that day or the nextdown 11.21%−11.5 pts vs Nifty 5002.2× its usual move · volume 4.3× usual
15 Apr 201412 filingsdown 14.67%−13.9 pts vs Nifty 5003.1× its usual move · volume 12.0× usual
2 Apr 20141 filingup 16.89%+16.1 pts vs Nifty 5004.3× its usual move · volume 8.4× usual
12 Mar 20142 filingsdown 19.74%−19.8 pts vs Nifty 5007.4× its usual move · volume 25.2× usual
17 Feb 20142 filingsdown 7.21%−7.5 pts vs Nifty 5003.4× its usual move · volume 0.2× usual
23 Jan 2014No filing that day or the nextup 10.00%+10.0 pts vs Nifty 5004.4× its usual move · volume 1.7× usual
10 Sep 20132 filingsup 19.91%+16.6 pts vs Nifty 5004.4× its usual move · volume 2.6× usual
6 Sep 2013No filing that day or the nextup 19.92%+18.6 pts vs Nifty 5005.3× its usual move · volume 2.3× usual
4 Sep 2013No filing that day or the nextup 9.88%+8.1 pts vs Nifty 5003.0× its usual move · volume 0.7× usual
26 Jul 20132 filingsdown 10.00%−9.5 pts vs Nifty 5003.0× its usual move · volume 2.6× usual
26 Feb 20131 filingdown 20.00%−18.4 pts vs Nifty 5004.9× its usual move · volume 0.7× usual
25 Feb 20131 filingdown 20.00%−19.8 pts vs Nifty 5006.4× its usual move · volume 0.9× usual
17 Jan 20136 filingsup 17.08%+16.6 pts vs Nifty 5007.5× its usual move · volume 8.3× usual
21 Nov 20122 filingsup 11.28%+10.6 pts vs Nifty 5005.4× its usual move · volume 9.7× usual
9 Aug 20126 filingsup 14.96%+15.2 pts vs Nifty 5006.1× its usual move · volume 7.5× usual
10 May 20125 filingsup 13.32%+13.4 pts vs Nifty 5003.3× its usual move · volume 5.4× usual
9 May 20123 filingsdown 16.31%−15.6 pts vs Nifty 5004.7× its usual move · volume 1.6× usual
18 Apr 20124 filingsup 17.95%+17.7 pts vs Nifty 5006.8× its usual move · volume 6.4× usual
15 Mar 20128 filingsup 7.59%+9.1 pts vs Nifty 5003.5× its usual move · volume 5.8× usual
20 Dec 2011No filing that day or the nextup 11.61%+13.3 pts vs Nifty 5002.5× its usual move · volume 2.0× usual

Last results date

Dr.Datsons Labs annual reports, presentations and earnings calls

Annual reports4

Dr.Datsons Labs share news and announcements

Jun 2018

Feb 2018

Jun 2015

May 2015

Apr 2015

Mar 2015

Feb 2015

Jan 2015

How the price met the news

Sharp moves